ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
62,099.04
-0.38%
S&P 500
5,187.70
0.00%
Dow Jones
38,884.26
0.00%
US Dollar vs Yen
155.612
0.56%
Brent Oil
82.39
-0.57%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. ARCA Biopharma Inc (ABIO)

  7. ARCA Biopharma Inc (ABIO) ニュース

ABIO

ARCA Biopharma (ABIO)

ARCA Biopharma Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ABIO
日付受信時刻ニュースソース見出しコード企業名
2024/04/2605 : 15GlobeNewswire Inc.ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:ABIOARCA Biopharma Inc
2024/04/0602 : 09PR Newswire (US)Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law FirmNASDAQ:ABIOARCA Biopharma Inc
2024/04/0320 : 30GlobeNewswire Inc.ARCA biopharma and Oruka Therapeutics Announce Merger AgreementNASDAQ:ABIOARCA Biopharma Inc
2024/04/0320 : 30GlobeNewswire Inc.ARCA biopharma and Oruka Therapeutics Announce Merger AgreementNASDAQ:ABIOARCA Biopharma Inc
2024/02/0803 : 08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ABIOARCA Biopharma Inc
2024/02/0706 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
2024/02/0206 : 39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
2024/02/0206 : 35GlobeNewswire Inc.ARCA biopharma Announces 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
2024/02/0206 : 15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ABIOARCA Biopharma Inc
2024/02/0108 : 39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
2024/02/0106 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
2024/02/0106 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
2024/02/0106 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
2024/02/0106 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
2024/02/0106 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
2024/02/0106 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
2024/02/0106 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
2023/12/2006 : 25Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ABIOARCA Biopharma Inc
2023/12/2006 : 20Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ABIOARCA Biopharma Inc
2023/12/2006 : 15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ABIOARCA Biopharma Inc
2023/12/0606 : 25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
2023/12/0506 : 36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
2023/10/1905 : 35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
2023/10/1905 : 25GlobeNewswire Inc.ARCA biopharma Announces Third Quarter 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
2023/10/1905 : 15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABIOARCA Biopharma Inc
2023/09/1205 : 01Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ABIOARCA Biopharma Inc
2023/07/2205 : 35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
2023/07/2205 : 25GlobeNewswire Inc.ARCA biopharma Announces Second Quarter 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
2023/07/2205 : 16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABIOARCA Biopharma Inc
2023/04/2505 : 36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABIOARCA Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:ABIO

最近閲覧した銘柄

USOTC
ADDYY
Adidas (QX)
NYSE
DIS
Walt Disney
FX
USDEUR
US Dollar vs Euro
COIN
BTCUSD
Bitcoin
CCOM
US30
US 30
AMEX
SPY
SPDR S&P 500
USOTC
DTEGY
Deutsche Telekom (QX)
FX
USDGBP
US Dollar vs Sterling
USOTC
RHHBY
Roche (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
GOOGL
Alphabet
AMEX
XLE
Energy Select Sector SPDR
FX
USDJPY
US Dollar vs Yen
USI
USTECH100
US Tech 100
NYSE
CVX
Chevron
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有